Skip to main content
. 2013 Nov 12;2013:789814. doi: 10.1155/2013/789814

Figure 2.

Figure 2

General scheme: dendritic cell therapy for Crohn's disease patients. Isolated monocytes are cultured and differentiated into DCs by adding IL-4 and GM-CSF to the media. At day 3, addition of dexamethasone induces the tolerogenic profile, and at day 6, addition of the maturation cytokine cocktail potentiates the tolerogenic properties.